Skip to main content

BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Shares Favre Interview

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a company focused on developing unique, life-saving medical products including a novel compound for the treatment of concussion, is sharing an interview by NFL Hall of Famer Brett Favre. During the interview, hosted by Bubba, the Love Sponge(R), Favre talks about the many concussions he received while playing football. Earlier this week, Favre did another interview with ODYY head of drug development Dr. Jacob VanLandingham, in which he also talked about concussions. During the interview with Bubba, the Love Sponge, Favre explained that when he left the NFL years ago, he thought he had experienced three concussions. Since then, he’s learned more about concussions and realized he’s actually had many more. “Concussions happen all the time,” said the NFL Hall of Famer Brett Favre during the interview. “You get tackled and your head hits the turf, you see flashes of light or ringing in your ears but you’re able to play — that’s a concussion. . . . So, based on that, [I’ve suffered] thousands. . . had to be, because every time my head hit the turf, there was ringing or stars going, flash bulbs. . . but I was still able to play. . . . That’s what’s kind of frightening about the concussion thing — it’s the ones that seem minor that do the damage ’cause you’re able to play and keep going.”

To view the full interview, visit

About Odyssey Health Inc. 

Odyssey Health (formerly Odyssey Group International) is a technology and asset acquisition company with a focus in the area of life-saving medical solutions. Odyssey’s corporate mission is to create, acquire and accumulate distinct assets, intellectual properties, and exceptional technologies that provide meaningful medical solutions. The company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, have a substantial market opportunity and provide solid returns to its valued shareholders and partners. For more information about the company, please visit

NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.